Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart M Cobbe

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Heart (British Cardiac Society)|May 16, 2007
Prediction of cognitive dysfunction after resuscitation from out-of-hospital cardiac arrest using serum neuron-specific enolase and protein S-100Neil R Grubb, Catriona Simpson, Roy A Sherwood, et al.
Circulation|May 22, 2002
Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) ProjectMarc A Pfeffer, Anthony Keech, Frank M Sacks, et al.
Nuclear Medicine Communications|March 13, 2010
I-123 MIBG cardiac uptake measurements: limitations of collimator choice and scatter correction in the clinical contextAlison M Fletcher, Duncan W Motherwell, Alexander D Small, et al.
Diabetes|October 27, 2004
Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention studyNaveed Sattar, Olga Scherbakova, Ian Ford, et al.
International Journal of Epidemiology|October 28, 2008
Adipocytokines and risk of stroke in older people: a nested case-control studyDavid J Stott, Paul Welsh, Ann Rumley, et al.
European Journal of Heart Failure|November 21, 2009
Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failureColette E Jackson, Jonathan R Dalzell, Vladimir Bezlyak, et al.
Circulation|July 16, 2003
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention StudyNaveed Sattar, Allan Gaw, Olga Scherbakova, et al.
Circulation|September 15, 2004
Effect of pravastatin on cardiovascular events in people with chronic kidney diseaseMarcello Tonelli, Chris Isles, Gary C Curhan, et al.
Circulation|July 7, 2005
Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary diseaseMarcello Tonelli, Chris Isles, Timothy Craven, et al.
Circulation|January 28, 2004
Metabolic syndrome and diabetes mellitusW E Feeman, Naveed Sattar, Denis St J OReilly, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Heart (British Cardiac Society)|May 16, 2007
Prediction of cognitive dysfunction after resuscitation from out-of-hospital cardiac arrest using serum neuron-specific enolase and protein S-100Neil R Grubb, Catriona Simpson, Roy A Sherwood, et al.
Circulation|May 22, 2002
Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) ProjectMarc A Pfeffer, Anthony Keech, Frank M Sacks, et al.
Nuclear Medicine Communications|March 13, 2010
I-123 MIBG cardiac uptake measurements: limitations of collimator choice and scatter correction in the clinical contextAlison M Fletcher, Duncan W Motherwell, Alexander D Small, et al.
Diabetes|October 27, 2004
Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention studyNaveed Sattar, Olga Scherbakova, Ian Ford, et al.
International Journal of Epidemiology|October 28, 2008
Adipocytokines and risk of stroke in older people: a nested case-control studyDavid J Stott, Paul Welsh, Ann Rumley, et al.
European Journal of Heart Failure|November 21, 2009
Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failureColette E Jackson, Jonathan R Dalzell, Vladimir Bezlyak, et al.
Circulation|July 16, 2003
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention StudyNaveed Sattar, Allan Gaw, Olga Scherbakova, et al.
Circulation|September 15, 2004
Effect of pravastatin on cardiovascular events in people with chronic kidney diseaseMarcello Tonelli, Chris Isles, Gary C Curhan, et al.
Circulation|July 7, 2005
Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary diseaseMarcello Tonelli, Chris Isles, Timothy Craven, et al.
Circulation|January 28, 2004
Metabolic syndrome and diabetes mellitusW E Feeman, Naveed Sattar, Denis St J OReilly, et al.
Pageof 6